Call:+1 7755157689
April 17, 2025


Contact Us

Volume 12

Persistent PTSD among Patients with Fragile X Syndrome: Case Series

1. Abstract 1.1. Background: Posttraumatic stress disorder (PTSD) affects about 3.6% of the US population and has clear diagnostic criteria and treatment modalities. Individuals with autism spectrum disorder (ASD) and intellectual disabilities (ID) are at an elevated risk for exposure to trauma and development of PTSD.

Persistent PTSD among Patients with Fragile X Syndrome: Case Series Read More »

Neuroprotective Roles of Oleic Acid: An Antioxidant Status and Cerebellar Characterization in Rat Models of Aluminium Chloride-Induced Alzheimer Disease

1. Abstract 1.1. Background: Previous studies have linked Alzheimer’s disease (AD) with cerebellar dysfunction. However, these studies lack substantial cerebellar characterization and features during AD progression.

Neuroprotective Roles of Oleic Acid: An Antioxidant Status and Cerebellar Characterization in Rat Models of Aluminium Chloride-Induced Alzheimer Disease Read More »

Emergent Operative Treatment of Aortic Dissection Years after Aortic Valve Balloon Dilatation, Ross Procedure, and Aortic Valve Replacement

1. Abstract This case report discusses a 38-year-old female with a history of congenital aortic stenosis who underwent the Ross procedure and subsequent aortic valve replacement (AVR) with a biological prosthesis.

Emergent Operative Treatment of Aortic Dissection Years after Aortic Valve Balloon Dilatation, Ross Procedure, and Aortic Valve Replacement Read More »

Malignant Pheochromocytoma – Disputable Differential Diagnostics and Follow-up Surgical Approach – Case Report

1. Introduction Malignant pheochromocytomas are rare endocrine tumors that develop within chromaffin tissue. The diagnosis of malignancy is based on neoplastic recurrence or the presence of metastasis in organs that lack chromaffin tissues [1].

Malignant Pheochromocytoma – Disputable Differential Diagnostics and Follow-up Surgical Approach – Case Report Read More »

The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call

1. Abstract The European Medicines Authority (EMA) is a decentralised agency of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU and the European economic Area (EEA). On July 11th, 2023, it issued a press release stating that PRAC (The EMA’s safety committee) was reviewing data on the potential risk of suicidal thoughts and thoughts of self-harm with medicines known as GLP-1 receptor agonists, including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide).

The EMA and Glucagon-Like Peptide-1 Agonists: A Wake-Up Call Read More »

We Need to Rehabilitate the Brains of Individuals with Parkinson’s Disease: The Incredible Gains with Transcranial Direct Current Electrostimulation (tDCS)

1. Case Report Parkinsonian syndromes are determined by the presence of at least two of the four main symptoms: bradykinesia, rigidity, resting tremor and postural instability [2, 18], caused by a reduction in dopamine in the pars Compacta of the substantia nigra [6].

We Need to Rehabilitate the Brains of Individuals with Parkinson’s Disease: The Incredible Gains with Transcranial Direct Current Electrostimulation (tDCS) Read More »

You cannot copy content of this page